Quality & Testing

Disulfide Bonds: Why the Right Mass Does Not Prove the Right Fold

Two peptide vials on a lab bench joined by a loop of fine stainless steel chain, Revoryn Labs Research Library

A cysteine-containing peptide has a second identity problem on top of its sequence. The sequence says which residues are present and in what order; it does not say which cysteines are joined to which. Two molecules with identical sequences and identical masses can have completely different disulfide pairings, and therefore completely different shapes.

This one is not a subtlety of instrument resolution. It is a structural limit of what a mass measurement can establish.

Quick answer

Does a correct mass confirm that a peptide's disulfide bonds are right? No. Forming each disulfide removes two hydrogens, so the mass drops by 2.0157 Da per bridge — which means a mass measurement can tell you how many bridges formed, but not which cysteines are paired. Every possible pairing of the same cysteines gives the same mass, so a scrambled isomer is isobaric with the correct fold. Published work on disulfide analysis states plainly that connectivity in multiply bridged peptides cannot be determined directly through a simple, sufficiently validated sequencing or peptide mapping method; partial or complete reduction and chemical modification of the cysteines are required first.

The arithmetic, and what it buys you

Two cysteine thiols (SH) oxidise to a disulfide (S-S), releasing two hydrogen atoms. The monoisotopic mass of hydrogen is 1.00783 Da, so:

  • One disulfide: −2.0157 Da relative to the fully reduced peptide
  • Two disulfides: −4.0313 Da
  • Three disulfides: −6.0470 Da

This is genuinely useful information. Comparing the observed mass against the fully reduced calculation tells you the oxidation state — how many bridges are present — and that is a real check worth doing. Our note on reading the mass data is here.

What it does not tell you is the pairing, and the number of possibilities grows quickly.

Cysteines Disulfides Possible pairings Distinguishable by mass?
2 1 1 Not applicable — only one option
4 2 3 No. All isobaric.
6 3 15 No. All isobaric.
8 4 105 No. All isobaric.

With a single bridge there is no ambiguity, because there is only one way to pair two cysteines. From four cysteines upward, the mass is silent on which of several distinct molecules you are holding.

What it takes to actually establish connectivity

The standard approach is to cut the peptide into fragments under conditions that leave the disulfides intact, then identify which fragments remain tethered together. In practice this is harder than it sounds, and the literature is candid about it.

A 2024 evaluation of cysteine detection methods opens by stating that despite ongoing efforts it is still not possible to detect disulfide bonds and the connectivity of multiply bridged peptides directly through a simple and sufficiently validated protein sequencing or peptide mapping method, and that partial or complete reduction together with chemical cysteine modification are required as initial steps before any detection method is applied. That study went back to Edman degradation, using phenylthiohydantoin cysteine derivatives as reference standards, and determined connectivity for model peptides and for human insulin entirely independently of mass spectrometry.

Where MS is used, the workable methods all involve controlled partial reduction so that intermediate species reveal which fragments were linked. Reported approaches include partial reduction in the ion source, online photochemical reduction in a flow microreactor before ionisation, and post-column addition of a reducing agent so that a disulfide-linked peptide and its reduced daughters co-elute and are detected together. The common feature is that none of them read connectivity off an intact-mass measurement, because that measurement does not contain the information.

The scale of the difficulty is visible in the reported results. One online photochemical reduction method raised sequence coverage for lysozyme from 35% to 100% and determined all four of its disulfide bonds; for bovine serum albumin, with seventeen disulfides, coverage rose from 13% to 87% and nine bonds were characterised, with eight adjacent bonds narrowed down rather than resolved.

Scrambling: the isobaric failure mode

Disulfide scrambling is the formation of the wrong pairings — a molecule with the right sequence, the right number of bridges and the right mass, folded incorrectly. It can occur during synthesis, during oxidative folding, or later under conditions that allow thiol-disulfide exchange, which is favoured at alkaline pH and in the presence of residual free thiol.

Because scrambled forms are isobaric with the correct fold, they are invisible to the measurement most likely to be performed. Work on monoclonal antibodies describes scrambling as something that can exist but be difficult to detect, let alone characterise, particularly at low levels — and that is in a setting with far more analytical effort than research-grade peptide supply receives.

Reversed-phase HPLC offers partial help, as it does for racemisation: a scrambled isomer has a different shape and may separate from the correctly folded form. Whether it does under a given gradient is not guaranteed. The parallel with racemisation and D-amino acids is close, and so is the consequence — if the isomer co-elutes, its area is counted as product.

Why correct pairing matters

Disulfide bridges are the main covalent constraint on a small peptide's three-dimensional shape. The disulfide mapping literature puts it directly: protein stability, structure and function depend on correct cysteine connectivity. For a constrained peptide, the bridges are the structure; the same chain folded differently is a different molecule in every respect that matters except formula.

The practical consequence for a research setting is that two lots can carry different proportions of scrambled material while reporting the same sequence, the same mass and a similar purity figure. Nothing on a conventional certificate would distinguish them.

First, check whether this applies to you at all

Many short synthetic research peptides contain no cysteine, in which case none of this is relevant. Reading the sequence settles it in seconds — see reading a peptide sequence.

Sequence Cysteines Does this article apply?
BPC-157 — GEPPPGKPADDAGLV None No. No disulfide chemistry to get wrong.
Epitalon — Ala-Glu-Asp-Gly None No.
MOTS-c — MRWQEMGYIFYPRKLR None No. Its sulfur is in two methionines, which is an oxidation question rather than a bridging one.
Any sequence containing two or more Cys Two or more Yes, and the ambiguity begins at four cysteines.

Note the distinction in the third row. Methionine contains sulfur but does not form disulfides; it oxidises to the sulfoxide, adding 16 Da. That is a different reaction with a different signature, covered in oxidation, deamidation and aggregation. Cyclisation through a lactam bridge, as in MT-2, is also a different thing — see reading the modifications in a peptide name.

What is reasonable to ask for

  • The observed mass against the fully reduced calculation, so the oxidation state can be checked. This is a legitimate request and the data usually exists.
  • Whether connectivity was determined at all, and by what method. For research-grade material the answer is usually no, and that is normal — but it should be stated rather than implied by a correct mass.
  • Whether any free thiol was measured. Residual free cysteine indicates incomplete oxidation and is also what enables later scrambling.
  • Storage guidance specific to the compound. Alkaline conditions and free thiol both promote exchange.

None of this is a demand that a research supplier perform pharmaceutical-grade characterisation. It is about not reading a mass measurement as an answer to a question it cannot address, which is the same discipline described in what 99% purity actually means.

Key takeaways

  • Each disulfide removes 2.0157 Da. Mass tells you how many bridges formed, not which cysteines are joined.
  • Four cysteines allow three possible pairings; six allow fifteen. All are isobaric.
  • Published work states that connectivity cannot be read directly from a simple validated peptide mapping method — reduction and chemical cysteine modification are required first.
  • Working MS approaches all rely on controlled partial reduction, because intact mass does not contain the information.
  • Scrambled disulfides have the correct sequence, bridge count and mass, and are difficult to detect at low levels.
  • Reversed-phase HPLC may separate a scrambled isomer, or may not. Co-elution counts it as product.
  • Many short research peptides contain no cysteine at all. Read the sequence before worrying about any of this.

Frequently asked questions

If the mass is right, how can the fold be wrong?

Because every arrangement of the same bridges gives the same mass. Mass measures composition; connectivity is arrangement. A scrambled isomer has identical composition and different arrangement, so it is a different molecule with an identical formula.

Does a single disulfide have this problem?

No. With exactly two cysteines there is only one way to pair them, so a correct mass plus the correct bridge count does establish the structure. The ambiguity starts at four cysteines.

Can HPLC detect scrambling?

Sometimes. A differently folded isomer has a different shape and can elute separately. Whether it resolves under the specific gradient used is not guaranteed, and a generic method is not evidence of absence.

What causes scrambling after manufacture?

Thiol-disulfide exchange, which is promoted by alkaline pH and by the presence of free thiol. This is one reason buffer pH is not a free choice for cysteine-containing peptides — see peptide buffers and pH.

Should a research certificate include disulfide mapping?

Realistically no, and its absence is not a deficiency. What matters is that the certificate does not present a matching mass as proof of correct folding, and that you know the difference when reading it. Our field-by-field guide is the certificate of analysis glossary.

Sources

  • Elsayed YY, Kühl T, Imhof D. Edman degradation reveals unequivocal analysis of the disulfide connectivity in peptides and proteins. Anal Chem. 2024;96(10):4057–4066. DOI
  • Cramer CN, Kelstrup CD, Olsen JV, Haselmann KF, Nielsen PK. Generic workflow for mapping of complex disulfide bonds using in-source reduction and extracted ion chromatograms from data-dependent mass spectrometry. Anal Chem. 2018;90(13):8202–8210. DOI
  • Yang X, Xia Y. Mapping complex disulfide bonds via implementing photochemical reduction online with liquid chromatography-mass spectrometry. J Am Soc Mass Spectrom. 2021;32(1):307–314. DOI
  • Kleinberg A, Joseph R, Mao Y, Li N. Ultrasensitive disulfide scrambling analysis of mAbs by LC-MS with post-column reduction and glycine signal enhancement. Anal Biochem. 2022;653:114773. DOI

Citations retrieved via PubMed. Mass values are calculated from standard monoisotopic atomic masses.

This article describes structural and analytical chemistry only. It contains no usage instructions, no dosing information and no protocols of any kind.

For laboratory and in-vitro research use only. Not for human or veterinary use.

For laboratory and in-vitro research use only. Not for human or veterinary use. See our research-use disclaimer.